AxoGen, Inc. (0HKD.L)
USD 14.81
(0.75%)
USD 14.81
(0.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 127.87 Million USD | 11.74% |
| 2022 | 114.43 Million USD | 9.59% |
| 2021 | 104.42 Million USD | 15.11% |
| 2020 | 90.71 Million USD | 1.52% |
| 2019 | 89.36 Million USD | 25.84% |
| 2018 | 71.01 Million USD | 38.93% |
| 2017 | 51.11 Million USD | 47.56% |
| 2016 | 34.64 Million USD | 54.08% |
| 2015 | 22.48 Million USD | 68.09% |
| 2014 | 13.37 Million USD | 57.22% |
| 2013 | 8.5 Million USD | 48.48% |
| 2012 | 5.72 Million USD | 136.48% |
| 2011 | 2.42 Million USD | 2554.59% |
| 2010 | 91.27 Thousand USD | -99.63% |
| 2009 | 24.91 Million USD | 34160.81% |
| 2008 | 72.71 Thousand USD | -27.6% |
| 2007 | 100.43 Thousand USD | -20.71% |
| 2006 | 126.66 Thousand USD | -71.43% |
| 2005 | 443.35 Thousand USD | -58.37% |
| 2004 | 1.06 Million USD | -38.85% |
| 2003 | 1.74 Million USD | 6.22% |
| 2002 | 1.63 Million USD | -69.76% |
| 2001 | 5.42 Million USD | -10.06% |
| 2000 | 6.02 Million USD | 20.58% |
| 1999 | 5 Million USD | 11.11% |
| 1998 | 4.5 Million USD | -16.67% |
| 1997 | 5.4 Million USD | -11.48% |
| 1996 | 6.1 Million USD | -7.58% |
| 1995 | 6.6 Million USD | 43.48% |
| 1994 | 4.6 Million USD | 17.95% |
| 1993 | 3.9 Million USD | 8.33% |
| 1992 | 3.6 Million USD | 9.09% |
| 1991 | 3.3 Million USD | 10.0% |
| 1990 | 3 Million USD | -3.23% |
| 1989 | 3.1 Million USD | -3.13% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 32.62 Million USD | -3.39% |
| 2024 Q2 | 35.34 Million USD | 8.35% |
| 2023 Q4 | 33.76 Million USD | 1.61% |
| 2023 Q2 | 30.92 Million USD | 3.24% |
| 2023 Q3 | 33.22 Million USD | 7.44% |
| 2023 Q1 | 29.95 Million USD | -0.23% |
| 2023 FY | 127.87 Million USD | 11.74% |
| 2022 Q2 | 28.17 Million USD | 10.64% |
| 2022 Q3 | 30.78 Million USD | 9.28% |
| 2022 Q4 | 30.02 Million USD | -2.47% |
| 2022 Q1 | 25.46 Million USD | -2.48% |
| 2022 FY | 114.43 Million USD | 9.59% |
| 2021 Q3 | 25.96 Million USD | -1.97% |
| 2021 Q1 | 25.86 Million USD | -4.32% |
| 2021 FY | 104.42 Million USD | 15.11% |
| 2021 Q4 | 26.1 Million USD | 0.55% |
| 2021 Q2 | 26.48 Million USD | 2.41% |
| 2020 Q1 | 19.44 Million USD | -16.48% |
| 2020 FY | 90.71 Million USD | 1.52% |
| 2020 Q4 | 27.03 Million USD | -2.52% |
| 2020 Q3 | 27.73 Million USD | 67.95% |
| 2020 Q2 | 16.51 Million USD | -15.09% |
| 2019 Q1 | 19.57 Million USD | -1.12% |
| 2019 FY | 89.36 Million USD | 25.84% |
| 2019 Q3 | 24.05 Million USD | 7.11% |
| 2019 Q4 | 23.28 Million USD | -3.21% |
| 2019 Q2 | 22.45 Million USD | 14.75% |
| 2018 Q3 | 19.19 Million USD | 9.83% |
| 2018 Q4 | 19.79 Million USD | 3.11% |
| 2018 FY | 71.01 Million USD | 38.93% |
| 2018 Q2 | 17.47 Million USD | 20.15% |
| 2018 Q1 | 14.54 Million USD | 1.33% |
| 2017 Q1 | 10.32 Million USD | 7.79% |
| 2017 Q2 | 12.89 Million USD | 24.85% |
| 2017 Q3 | 13.54 Million USD | 5.05% |
| 2017 FY | 51.11 Million USD | 47.56% |
| 2017 Q4 | 14.35 Million USD | 6.02% |
| 2016 Q2 | 8.84 Million USD | 31.93% |
| 2016 Q1 | 6.7 Million USD | 4.89% |
| 2016 FY | 34.64 Million USD | 54.08% |
| 2016 Q3 | 9.5 Million USD | 7.46% |
| 2016 Q4 | 9.57 Million USD | 0.75% |
| 2015 FY | 22.48 Million USD | 68.09% |
| 2015 Q4 | 6.39 Million USD | -5.19% |
| 2015 Q1 | 3.96 Million USD | 3.43% |
| 2015 Q2 | 5.37 Million USD | 35.5% |
| 2015 Q3 | 6.74 Million USD | 25.4% |
| 2014 Q1 | 2.43 Million USD | 2.02% |
| 2014 FY | 13.37 Million USD | 57.22% |
| 2014 Q4 | 3.83 Million USD | 1.63% |
| 2014 Q3 | 3.77 Million USD | 13.49% |
| 2014 Q2 | 3.32 Million USD | 36.5% |
| 2013 Q4 | 2.38 Million USD | 3.53% |
| 2013 Q2 | 2.22 Million USD | 40.84% |
| 2013 Q1 | 1.58 Million USD | 1.04% |
| 2013 FY | 8.5 Million USD | 48.48% |
| 2013 Q3 | 2.3 Million USD | 3.51% |
| 2012 Q4 | 1.56 Million USD | 8.88% |
| 2012 FY | 5.72 Million USD | 136.48% |
| 2012 Q3 | 1.43 Million USD | -4.77% |
| 2012 Q2 | 1.51 Million USD | 24.4% |
| 2012 Q1 | 1.21 Million USD | 46.56% |
| 2011 Q1 | 3.62 Million USD | 8506.99% |
| 2011 Q2 | 2.24 Million USD | -38.09% |
| 2011 Q3 | 10.43 Thousand USD | -99.53% |
| 2011 FY | 2.42 Million USD | 2554.59% |
| 2011 Q4 | 828.51 Thousand USD | 7839.0% |
| 2010 Q3 | 26.37 Thousand USD | 710.48% |
| 2010 Q4 | 42.11 Thousand USD | 59.7% |
| 2010 FY | 91.27 Thousand USD | -99.63% |
| 2010 Q1 | 19.52 Thousand USD | -99.92% |
| 2010 Q2 | 3254.00 USD | -83.34% |
| 2009 Q4 | 24.23 Million USD | 99981.53% |
| 2009 FY | 24.91 Million USD | 34160.81% |
| 2009 Q3 | 24.21 Thousand USD | -96.03% |
| 2009 Q1 | 42.1 Thousand USD | 29.22% |
| 2009 Q2 | 610.31 Thousand USD | 1349.43% |
| 2008 FY | 72.71 Thousand USD | -27.6% |
| 2008 Q1 | 21.02 Thousand USD | 0.0% |
| 2008 Q4 | 32.58 Thousand USD | 132.39% |
| 2008 Q3 | 14.02 Thousand USD | 176.3% |
| 2008 Q2 | 5075.00 USD | -75.87% |
| 2007 FY | 100.43 Thousand USD | -20.71% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q3 | 34.38 Thousand USD | 0.0% |
| 2006 Q2 | - USD | -100.0% |
| 2006 Q1 | 92.27 Thousand USD | -63.69% |
| 2006 FY | 126.66 Thousand USD | -71.43% |
| 2006 Q4 | - USD | -100.0% |
| 2005 FY | 443.35 Thousand USD | -58.37% |
| 2005 Q3 | 68.71 Thousand USD | 203.1% |
| 2005 Q2 | -66.65 Thousand USD | -181.99% |
| 2005 Q1 | 81.29 Thousand USD | 0.0% |
| 2005 Q4 | 254.15 Thousand USD | 269.86% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | 745.76 Thousand USD | 43.46% |
| 2004 Q2 | 373.27 Thousand USD | -49.95% |
| 2004 FY | 1.06 Million USD | -38.85% |
| 2004 Q3 | - USD | -100.0% |
| 2003 Q1 | 491.29 Thousand USD | 452.08% |
| 2003 Q2 | 391 Thousand USD | -20.41% |
| 2003 Q4 | 519.84 Thousand USD | 53.13% |
| 2003 FY | 1.74 Million USD | 6.22% |
| 2003 Q3 | 339.47 Thousand USD | -13.18% |
| 2002 Q1 | 488.35 Thousand USD | 0.0% |
| 2002 Q4 | 88.99 Thousand USD | -85.03% |
| 2002 Q3 | 594.27 Thousand USD | 26.98% |
| 2002 Q2 | 468 Thousand USD | -4.17% |
| 2002 FY | 1.63 Million USD | -69.76% |
| 2001 FY | 5.42 Million USD | -10.06% |
| 2001 Q3 | 941 Thousand USD | 88.14% |
| 2001 Q2 | 500.15 Thousand USD | -68.78% |
| 2001 Q1 | 1.6 Million USD | 5.22% |
| 2000 Q2 | 1.8 Million USD | 5.17% |
| 2000 FY | 6.02 Million USD | 20.58% |
| 2000 Q1 | 1.71 Million USD | 22.79% |
| 2000 Q3 | 1.79 Million USD | -0.53% |
| 2000 Q4 | 1.52 Million USD | -15.35% |
| 1999 Q1 | 1.3 Million USD | 18.18% |
| 1999 FY | 5 Million USD | 11.11% |
| 1999 Q4 | 1.4 Million USD | 27.27% |
| 1999 Q3 | 1.1 Million USD | -15.38% |
| 1999 Q2 | 1.3 Million USD | 0.0% |
| 1998 Q1 | 1 Million USD | -9.09% |
| 1998 Q3 | 1.2 Million USD | 20.0% |
| 1998 Q4 | 1.1 Million USD | -8.33% |
| 1998 FY | 4.5 Million USD | -16.67% |
| 1998 Q2 | 1 Million USD | 0.0% |
| 1997 Q2 | 1.4 Million USD | 7.69% |
| 1997 Q4 | 1.1 Million USD | -21.43% |
| 1997 FY | 5.4 Million USD | -11.48% |
| 1997 Q1 | 1.3 Million USD | 0.0% |
| 1997 Q3 | 1.4 Million USD | 0.0% |
| 1996 Q4 | 1.3 Million USD | -7.14% |
| 1996 Q2 | 1.2 Million USD | -33.33% |
| 1996 FY | 6.1 Million USD | -7.58% |
| 1996 Q1 | 1.8 Million USD | 20.0% |
| 1996 Q3 | 1.4 Million USD | 16.67% |
| 1995 Q2 | 1.6 Million USD | -15.79% |
| 1995 Q4 | 1.5 Million USD | -11.76% |
| 1995 FY | 6.6 Million USD | 43.48% |
| 1995 Q3 | 1.7 Million USD | 6.25% |
| 1995 Q1 | 1.9 Million USD | 26.67% |
| 1994 Q4 | 1.5 Million USD | 0.0% |
| 1994 FY | 4.6 Million USD | 17.95% |
| 1994 Q1 | 900 Thousand USD | -10.0% |
| 1994 Q2 | 1.2 Million USD | 33.33% |
| 1994 Q3 | 1.5 Million USD | 25.0% |
| 1993 Q2 | 1 Million USD | 0.0% |
| 1993 Q1 | 1 Million USD | 25.0% |
| 1993 FY | 3.9 Million USD | 8.33% |
| 1993 Q4 | 1 Million USD | -28.57% |
| 1993 Q3 | 1.4 Million USD | 40.0% |
| 1992 Q1 | 1 Million USD | 11.11% |
| 1992 Q2 | 800 Thousand USD | -20.0% |
| 1992 Q3 | 1.1 Million USD | 37.5% |
| 1992 Q4 | 800 Thousand USD | -27.27% |
| 1992 FY | 3.6 Million USD | 9.09% |
| 1991 Q1 | 800 Thousand USD | -11.11% |
| 1991 Q4 | 900 Thousand USD | 0.0% |
| 1991 Q3 | 900 Thousand USD | 12.5% |
| 1991 FY | 3.3 Million USD | 10.0% |
| 1991 Q2 | 800 Thousand USD | 0.0% |
| 1990 FY | 3 Million USD | -3.23% |
| 1990 Q3 | 800 Thousand USD | 112.5% |
| 1990 Q4 | 900 Thousand USD | 12.5% |
| 1990 Q1 | 5.2 Million USD | 57.58% |
| 1990 Q2 | -6.4 Million USD | -223.08% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 Q4 | 3.3 Million USD | 266.67% |
| 1989 FY | 3.1 Million USD | -3.13% |
| 1989 Q3 | 900 Thousand USD | -43.75% |
| 1989 Q2 | 1.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | 36.616% |
| Accuray Incorporated | 143.12 Million USD | 10.653% |
| Align Technology, Inc. | 2.72 Billion USD | 95.299% |
| Elevance Health Inc. | 47.01 Billion USD | 99.728% |
| Boston Scientific Corporation | 9.84 Billion USD | 98.702% |
| CVS Health Corporation | 54.43 Billion USD | 99.765% |
| Cardinal Health, Inc. | 7.41 Billion USD | 98.275% |
| Centene Corporation | 153.99 Billion USD | 99.917% |
| DaVita Inc. | 3.82 Billion USD | 96.653% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 99.768% |
| Hologic, Inc. | 2.23 Billion USD | 94.286% |
| Humana Inc. | 106.44 Billion USD | 99.88% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 94.161% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 96.2% |
| Masimo Corporation | 1 Billion USD | 87.257% |
| McKesson Corporation | 12.58 Billion USD | 98.984% |
| Patterson Companies, Inc. | 1.38 Billion USD | 90.735% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 95.681% |
| ResMed Inc. | 2.6 Billion USD | 95.098% |
| Henry Schein, Inc. | 3.65 Billion USD | 96.498% |
| Teladoc Health, Inc. | 1.84 Billion USD | 93.059% |
| Universal Health Services, Inc. | 1.17 Billion USD | 89.121% |
| Veeva Systems Inc. | 1.68 Billion USD | 92.417% |
| Baxter International Inc. | 4.97 Billion USD | 97.43% |
| Becton, Dickinson and Company | 8.82 Billion USD | 98.551% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 97.296% |
| Danaher Corporation | 14.12 Billion USD | 99.095% |
| Stryker Corporation | 13.05 Billion USD | 99.021% |
| Medtronic plc | 21.27 Billion USD | 99.399% |